Butyl isothiocyanate

Butyl isothiocyanate inhibits the proliferation of breast cancer cells. Butyl isothiocyanate can inhibit carcinogen activating phase I enzymes and inhibits cancer cell proliferation through altering the telomerase activity, dynamics of microtubules as well as expression of histone deacetylases. Butyl isothiocyanate can be studied in anti-cancer research[1][2].

Product Specifications

CAS Number

[592-82-5]

UNSPSC

12352211

Hazard Statement

H227, H302, H312, H314, H317, H318, H332, H334

Target

Biochemical Assay Reagents

Related Pathways

Others

Field of Research

Cancer

Purity

98.0

Smiles

S=C=NCCCC

Molecular Formula

C5H9NS

Molecular Weight

115.20

Precautions

H227, H302, H312, H314, H317, H318, H332, H334

References & Citations

[1]Singh, D., et al., (2020) . Molecular targets in cancer prevention by 4- (methylthio) butyl isothiocyanate - A comprehensive review. Life sciences, 241, 117061. |[2]Prełowska, M., et al., (2017) . 4- (Methylthio) butyl isothiocyanate inhibits the proliferation of breast cancer cells with different receptor status. Pharmacological reports : PR, 69 (5), 1059-1066.